Business as usual in Amsterdam – European Biotechnology
European Biotechnology |
Business as usual in Amsterdam
European Biotechnology David Venables from Edinburgh-based Synpromics Ltd. promoted the company's synthetic biology approach to transcriptional regulation that could catalyse a new generation of gene therapies: “Our idea is to have promoters that can be induced by … |
